Premium
A helper T‐cell antigen enhances generation of hepatitis C virus‐specific cytotoxic T lymphocytes in vitro
Author(s) -
Kita Hiroto,
Miura Hideaki,
Nakamura Ikuo,
Inamori Hideaki,
Kaneko Takashi,
Ohnishi Shin,
Yazaki Yoshio,
Moriyama Takashi,
Kodama Tatsuhiko,
Hiroishi Kazumasa,
Imawari Michio,
Harase Ichiro
Publication year - 1995
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890450406
Subject(s) - cytotoxic t cell , epitope , virology , t cell , biology , antigen , hepatitis c virus , virus , in vitro , immunology , immune system , biochemistry
A T‐cell help for generation of hepatitis C virus‐specific cytotoxic T lymphocytes was studied in three patients with chronic hepatitis C. In all three, human leukocyte antigen B44‐restricted cytotoxic T lymphocytes recognizing an epitope in hepatitis C virus nucleocapsid protein residues 81–100 were generated from the peripheral blood lymphocytes by repeated stimulation with a synthetic hepatitis C virus nucleocapsid pep‐tide. The proliferative response of peripheral blood lymphocytes to hepatitis C virus nucleocapsid protein residues 1–120 was observed in one patient, and was ascribed to CD4 + T cells. The helper T cells recognized a major epitope in residues 21–40 and a minor epitope(s) in residues 81–110. They produced interferon γ, but interleukin 4 was not detectable in the T‐helper cell culture supernatants. The hepatitis C virus nucleocapsid protein residues 1–120 and the major helper T‐cell epitope enhanced generation of hepatitis C virus‐specific cytotoxic T lymphocytes in vitro, although the protein alone did not generate them. In the other two patients, the protein did not enhance generation of hepatitis C virus‐specific cytotoxic T lymphocytes in vitro. The results suggest that a hepatitis C virus‐specific helper T‐cell epitope is helpful for inducing a strong specific cytotoxic T‐lymphocyte response. © 1995 Wiley‐Liss, Inc.